Intimation of closure of trading window of the Jenburkt Pharmaceuticals Limited as per the SEBI(Prohibition of Insider Trading) Regulations, 2015.

Ref.: JPL/CS/2353/2026. Date: 22nd September, 2026. BSE Ltd., Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001. Script Code : 524731 Sub. : Closure of Trading Window under “Jenburkt Pharmaceuticals Limited’s Code on Prohibition of Insider Trading”. Dear Sir, With reference to captioned code of the Company, read with Securities and Exchange of Board of India (Prohibition of Insider Trading) Regulations 2015, kindly take note that the trading window for all the trades in the equity shares of the Company by any of the designated persons, insiders and connected persons of the Company, including their relative(s), shall remain closed from 1st October, 2026, till 48 hours after the price sensitive information viz. standalone unaudited financial results, pertaining to the quarter and half year ending on 30th September, 2026, are disseminated or made public. The Company shall intimate the exchange separately about the schedule of Board Meeting for considering the said unaudited financial results, in due course. Request to take on record the above. Thanking you, Yours faithfully, For Jenburkt Pharmaceuticals Limited, Ashish R. Shah Sr. VP and Company Secretary and Compliance Officer.